Insider Transactions in Q1 2022 at Sarepta Therapeutics, Inc. (SRPT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
Stephen Mayo |
BUY
Grant, award, or other acquisition
|
Direct |
2,953
+28.96%
|
-
|
|
Mar 07
2022
|
Richard Barry |
BUY
Grant, award, or other acquisition
|
Direct |
2,953
+0.1%
|
-
|
|
Mar 07
2022
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
2,953
+2.09%
|
-
|
|
Mar 07
2022
|
Hans Lennart Rudolf Wigzell |
BUY
Grant, award, or other acquisition
|
Direct |
2,953
+13.17%
|
-
|
|
Mar 07
2022
|
Mary Ann Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,953
+19.29%
|
-
|
|
Mar 07
2022
|
Claude Nicaise |
BUY
Grant, award, or other acquisition
|
Direct |
2,953
+16.63%
|
-
|
|
Mar 07
2022
|
Louise Rodino Klapac Head of R&D, CSO |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+9.99%
|
-
|
|
Mar 07
2022
|
William Ciambrone EVP |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+26.58%
|
-
|
|
Mar 07
2022
|
Ryan Edward Brown EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+23.6%
|
-
|
|
Mar 07
2022
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
153
-0.85%
|
$12,087
$79.36 P/Share
|
|
Mar 07
2022
|
Ian Michael Estepan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+19.67%
|
-
|
|
Mar 07
2022
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
398
-1.59%
|
$31,442
$79.36 P/Share
|
|
Mar 04
2022
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,216
-1.86%
|
$96,064
$79.2 P/Share
|
|
Mar 04
2022
|
William Ciambrone EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,160
-7.6%
|
$91,640
$79.2 P/Share
|
|
Mar 04
2022
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,136
-5.92%
|
$89,744
$79.2 P/Share
|
|
Mar 04
2022
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,308
-4.96%
|
$103,332
$79.2 P/Share
|
|
Mar 01
2022
|
Ryan Edward Brown EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
184
-0.95%
|
$13,800
$75.05 P/Share
|
|
Mar 01
2022
|
Ian Michael Estepan Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
376
-1.41%
|
$28,200
$75.05 P/Share
|
|
Mar 01
2022
|
Louise Rodino Klapac Head of R&D, CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
572
-0.87%
|
$42,900
$75.05 P/Share
|